Shares of Oxford BioMedica (OTCMKTS:OXBDF – Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $8.95, but opened at $8.17. Oxford BioMedica shares last traded at $8.17, with a volume of 190 shares traded.
Oxford BioMedica Stock Performance
The company has a debt-to-equity ratio of 3.08, a current ratio of 1.89 and a quick ratio of 1.67. The company has a 50-day simple moving average of $10.55 and a two-hundred day simple moving average of $8.89.
Oxford BioMedica Company Profile
Oxford BioMedica is a clinical-stage gene and cell therapy company headquartered in Oxford, United Kingdom. The company specializes in the development, manufacturing and commercialization of lentiviral vector delivery systems for use in treating serious diseases. Its proprietary LentiVector® platform underpins both in-house development programs and third-party collaborations, enabling the stable integration of therapeutic genes into target cells.
In its research pipeline, Oxford BioMedica is advancing candidates across ophthalmology, neuroscience and oncology indications.
See Also
- Five stocks we like better than Oxford BioMedica
- Buy this Gold Stock Before May 15th, 2026
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- Nvidia CEO Issues Bold Tesla Call
- What central banks are doing with gold right now
Receive News & Ratings for Oxford BioMedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford BioMedica and related companies with MarketBeat.com's FREE daily email newsletter.
